Cingulate Inc.
CINGNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CING. That does not mean none is planned.
Get an email about CING's next catalysts
Track Cingulate (CING) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
CING Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.48 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Clinical-stage pharmaceutical company developing ADHD treatments
CTx-1301-Dexmethylphenidate (titration only)
ADHD
CTx-1301 - Dexmethylphenidate
ADHD
CTx-1301-Dexmethylphenidate (randomized fixed dose)
ADHD
Dexmethylphenidate
ADHD
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CTx-1301-Dexmethylphenidate (titration only) | Phase 3 | ADHD | - | - |
CTx-1301 - Dexmethylphenidate | Phase 3 | ADHD | - | - |
CTx-1301-Dexmethylphenidate (randomized fixed dose) | Phase 3 | ADHD | - | - |
Dexmethylphenidate | Phase 2 | ADHD | - | - |
Frequently asked questions
What is in Cingulate Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Cingulate Inc.'s (CING) pipeline across Phase 3, Phase 2. Its lead program is CTx-1301 - Dexmethylphenidate (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Cingulate Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Cingulate Inc. (CING) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track CING biotech catalysts?→
Add CING to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Cingulate Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.